Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pineal Res ; 45(1): 79-85, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18284549

RESUMO

Pro-inflammatory and modulatory cytokines have an essential role in host defense against human and murine Trypanosoma cruzi infection. Control of T. cruzi parasitism during the acute phase of infection is considered to be critically dependent on direct macrophage activation by cytokines. Melatonin has been proposed to regulate the immune system by affecting cytokine production in immunocompetent cells, enhancing the production of several T helper (Th)1 cytokines. The aims of this work were to evaluate in rats, the influences of exogenous melatonin treatment on T. cruzi-infected host's immune responses. With this in mind, several immunological parameters were analyzed, including tumor necrosis factor-alpha, gamma-interferon, interleukin-12, nitric oxide (NO) and macrophage count. The melatonin therapy was provided in one of two different treatment regimens, that is, either beginning 7 days prior to infection or concomitant with the infection. Both treatments triggered an up-regulation of the immune response, with the concomitant treatment being more effective; in this case all cytokines studied, with exception of NO, displayed enhanced concentrations and there was a higher number of peritoneal macrophages, which displayed reduced concentrations under melatonin therapy. We conclude that melatonin plays a pivotal role in up-regulating the Th1 immune response thus controlling parasite replication.


Assuntos
Antiprotozoários/uso terapêutico , Doença de Chagas/imunologia , Doença de Chagas/prevenção & controle , Citocinas/biossíntese , Mediadores da Inflamação/fisiologia , Melatonina/fisiologia , Animais , Antiprotozoários/farmacologia , Células Cultivadas , Doença de Chagas/tratamento farmacológico , Doença de Chagas/metabolismo , Citocinas/metabolismo , Feminino , Humanos , Mediadores da Inflamação/uso terapêutico , Interferon gama/sangue , Masculino , Melatonina/uso terapêutico , Camundongos , Camundongos Endogâmicos C57BL , Ratos , Ratos Wistar , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/imunologia
2.
Dig Dis Sci ; 53(8): 2020-6, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18097753

RESUMO

The protective role of cyclophosphamide was studied in this work. Young male Calomys callosus were infected with Trypanosoma cruzi and allowed to age. Cyclophosphamide therapy was administered to animals during acute and late chronic phases of infection. Esophageal neurons were counted, displaying enhanced neuronal loss for the young and treated infected groups. For aged and cyclophosphamide treated animals, a protection was observed through a reduced loss of neurons as compared to the young and infected groups. Enhanced nitric oxide concentrations were observed for young animals as compared to aged counterparts. Splenocyte proliferation was reduced during the acute phase in comparison with those found in the chronic phase. Morphometry of neuronal body displayed a significant reduction concerning the area, perimeter, diameter and volume for aged animals as compared to young groups. These results indicate that the protective effects of cyclophosphamide together with process of neuroplasty of peripheral nervous system could lead to a protection against neuronal loss.


Assuntos
Doença de Chagas/tratamento farmacológico , Ciclofosfamida/farmacologia , Esôfago/inervação , Plexo Mientérico/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Fatores Etários , Animais , Arvicolinae , Morte Celular , Proliferação de Células/efeitos dos fármacos , Doença de Chagas/metabolismo , Doença de Chagas/patologia , Modelos Animais de Doenças , Masculino , Plexo Mientérico/parasitologia , Plexo Mientérico/patologia , Neurônios/parasitologia , Neurônios/patologia , Óxido Nítrico/metabolismo , Baço/efeitos dos fármacos , Baço/parasitologia , Trypanosoma cruzi
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...